# US 2025/0360241 A1 · Combination Ultra-Violet A (UVA) and Ultra-Violet C (UVC) System for Reduction and Inhibition of Growth of Pathogens

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0360241 A1
- Document ID: US20250360241A1
- Status: Published application
- Kind: A1
- Application number: 19/295,842
- Filed: 2025-08-11
- Published: 2025-11-27
- Earliest claimed: 2020-03-03
- Assignees: Helios Shield Ltd.
- Applicants: Helios Shield Ltd.
- Inventors: Andrew Clark Baird AUBERT
- Web page: https://patentgrep.com/patent/US20250360241A1

## CPC

- A61L 2/24: Apparatus using programmed or automatic operation
- A61L 2/10: Ultraviolet [UV] radiation
- A61L 2103/05: Living organisms or biological materials
- A61L 2103/75: Room floors or walls
- A61L 2202/11: Apparatus for generating biocidal substances, e.g. vaporisers, UV lamps
- A61L 2202/14: Means for controlling sterilisation processes, data processing, presentation and storage means, e.g. sensors, controllers, programs
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

A UVA/UVC system for reducing levels, on a surface, and inhibiting further growth of at least one pathogen on said surface, wherein said system has no deleterious effects on a human, in particular on a human eye or epidermis and dermis, wherein said system includes: at least one UVA light source; at least one UVC light source; and at least one controller connected to each of the at least one UVA light source and the at least one UVC light source, for controlling at least one parameter of each of the UVA light source and UVC light source.

## Claims

### Claim 1

A method of reducing levels, on a surface, and inhibiting further growth of at least one pathogen on said surface, wherein said method has no deleterious effects on a human, in particular on a human eye or epidermis and dermis, wherein said method comprises:
i) exposing said surface to at least one UVC light source for a period of time to reduce the level of least one pathogen on said surface;
ii) terminating the exposure of the at least one UVC light source on said surface;
iii) exposing said UVC exposed surface to at least one UVA light source for a period of time to inhibit growth of least one pathogen on said surface;
iv) terminating the exposure of the at least one UVA light source on said surface;
v) optionally repeating steps i) to iv) in order to maintain a desired level of least one pathogen on said surface.

### Claim 2 (depends on 1)

The method of claim 1, wherein said at least one UVC light source has an operating wavelength of from about 275 nanometers (nm) to about 295 nm.

### Claim 3 (depends on 1)

The method of claim 1, wherein said at least one UVC light source has an operating wavelength of about 275 nm.

### Claim 4 (depends on 1)

The method of claim 1, wherein said at least one UVA light source has an operating wavelength of from about 385 nm to about 400 nm.

### Claim 5 (depends on 1)

The method of claim 1, wherein said at least one UVA light source has an operating wavelength of about 400 nm.

### Claim 6 (depends on 1)

The method of claim 1, wherein said at least one UVC light source is a light emitting diode (LED).

### Claim 7 (depends on 1)

The method of claim 1, wherein said at least one UVA light source is a LED.

### Claim 8 (depends on 1)

The method of claim 1, wherein steps i) to iv) are controlled by at least one controller automatically cycling between emitting light from said at least one UVA light source and from said at least one UVC light source.

### Claim 9 (depends on 1)

The method of claim 1, wherein said at least one UVC light source has an emission at a power level and time duration to reduce at least one pathogen on a surface exposed to said at least one UVC light source.

### Claim 10 (depends on 1)

The method of claim 1, wherein the power level is selected to ensure the radiated emission from said at least one UVC light source is at a safe level for human eyes and epidermis and dermis.

### Claim 11 (depends on 1)

The method of claim 1, wherein the time duration is selected to ensure the radiated emission from said at least one UVC light source is at a safe exposure time for human eyes and epidermis and dermis.

### Claim 12 (depends on 1)

The method of claim 1, wherein said at least one UVA light source has an emission at a power level to inhibit growth of at least one pathogen on a surface exposed to said at least one UVC light source, while safe for human eyes and epidermis and dermis, regardless of the exposure time.

### Claim 13 (depends on 1)

The method of claim 1, wherein said at least one UVC light source has a power rating of from about 10 mW to about 100 W.

### Claim 14 (depends on 13)

The method of claim 13, wherein said at least one UVC light source has a power rating of 244 mW.

### Claim 15 (depends on 1)

The method of claim 1, wherein said at least one UVA light source has a power rating of from about 10 mW to about 100 W.

### Claim 16 (depends on 15)

The method of claim 15, wherein said at least one UVA light source has a power rating of 20 mW.

### Claim 17 (depends on 1)

The method of claim 1, wherein said method reduces the level of at least one pathogen on a surface by 1 to 100%.

### Claim 18 (depends on 17)

The method of claim 17 wherein said level is reduced by 10 to 20%.

### Claim 19 (depends on 1)

The method of claim 1, for the reduction of at least one pathogen selected from the group consisting of E. Coli K12, S. Epidermis and B. Subtilis.
